Inhibition of EGF-induced phospholipase C activation in A341 cells by erbstatin, a tyrosine kinase inhibitor
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 173 (1) , 208-211
- https://doi.org/10.1016/s0006-291x(05)81042-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitroCell, 1989
- Studies of Inositol Phospholipid-Specific Phospholipase CScience, 1989
- Antiphosphotyrosine Recovery of Phospholipase C Activity After EGF Treatment of A-431 CellsScience, 1988
- Inhibition of tyrosine protein kinase by synthetic erbstatin analogs.The Journal of Antibiotics, 1987
- Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.The Journal of Antibiotics, 1986
- PROTEIN-TYROSINE KINASESAnnual Review of Biochemistry, 1985
- Inositol trisphosphate, a novel second messenger in cellular signal transductionNature, 1984
- The role of protein kinase C in cell surface signal transduction and tumour promotionNature, 1984